These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30016454)

  • 1. Circulating 27-Hydroxycholesterol and Breast Cancer Risk: Results From the EPIC-Heidelberg Cohort.
    Lu DL; Le Cornet C; Sookthai D; Johnson TS; Kaaks R; Fortner RT
    J Natl Cancer Inst; 2019 Apr; 111(4):365-371. PubMed ID: 30016454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.
    Le Cornet C; Walter B; Sookthai D; Johnson TS; Kühn T; Herpel E; Kaaks R; Fortner RT
    Breast Cancer Res; 2020 Feb; 22(1):23. PubMed ID: 32075687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between lifestyle, dietary, reproductive, and anthropometric factors and circulating 27-hydroxycholesterol in EPIC-Heidelberg.
    Le Cornet C; Johnson TS; Lu DL; Kaaks R; Fortner RT
    Cancer Causes Control; 2020 Feb; 31(2):181-192. PubMed ID: 31938951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 27-Hydroxycholesterol, an Endogenous SERM, and Risk of Fracture in Postmenopausal Women: A Nested Case-Cohort Study in the Women's Health Initiative.
    Chang PY; Feldman D; Stefanick ML; McDonnell DP; Thompson BM; McDonald JG; Lee JS
    J Bone Miner Res; 2019 Jan; 34(1):59-66. PubMed ID: 30138538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study.
    DeRouen MC; Yang J; Li Y; Franke AA; Tome AN; White KK; Hernandez BY; Shvetsov Y; Setiawan V; Wu AH; Wilkens LR; Le Marchand L; Loo LWM; Cheng I
    Breast Cancer Res; 2023 Aug; 25(1):95. PubMed ID: 37580793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating RANKL and RANKL/OPG and Breast Cancer Risk by ER and PR Subtype: Results from the EPIC Cohort.
    Sarink D; Schock H; Johnson T; Overvad K; Holm M; Tjønneland A; Boutron-Ruault MC; His M; Kvaskoff M; Boeing H; Lagiou P; Papatesta EM; Trichopoulou A; Palli D; Pala V; Mattiello A; Tumino R; Sacerdote C; Bueno-de-Mesquita HBA; van Gils CH; Peeters PH; Weiderpass E; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Amiano P; Khaw KT; Travis R; Dossus L; Gunter M; Rinaldi S; Merritt M; Riboli E; Kaaks R; Fortner RT
    Cancer Prev Res (Phila); 2017 Sep; 10(9):525-534. PubMed ID: 28701332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I and risk of breast cancer by age and hormone receptor status-A prospective study within the EPIC cohort.
    Kaaks R; Johnson T; Tikk K; Sookthai D; Tjønneland A; Roswall N; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Dossus L; Rinaldi S; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Grioni S; Tumino R; Sacerdote C; Panico S; Buckland G; Argüelles M; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Gram IT; Lund E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Jun; 134(11):2683-90. PubMed ID: 24248481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D supplementation decreases serum 27-hydroxycholesterol in a pilot breast cancer trial.
    Going CC; Alexandrova L; Lau K; Yeh CY; Feldman D; Pitteri SJ
    Breast Cancer Res Treat; 2018 Feb; 167(3):797-802. PubMed ID: 29116467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
    Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
    Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
    Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.
    Fortner RT; Sarink D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Affret A; His M; Boutron-Ruault MC; Boeing H; Trichopoulou A; Naska A; Orfanos P; Palli D; Sieri S; Mattiello A; Tumino R; Ricceri F; Bueno-de-Mesquita HB; Peeters PH; Van Gils CH; Weiderpass E; Lund E; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Ardanaz E; Dorronsoro M; Key T; Khaw KT; Rinaldi S; Dossus L; Gunter M; Merritt MA; Riboli E; Kaaks R
    BMC Med; 2017 Feb; 15(1):26. PubMed ID: 28173834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer.
    Kimbung S; Chang CY; Bendahl PO; Dubois L; Thompson JW; McDonnell DP; Borgquist S
    Endocr Relat Cancer; 2017 Jul; 24(7):339-349. PubMed ID: 28442559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
    Tikk K; Sookthai D; Fortner RT; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Masala G; Krogh V; Tumino R; Ricceri F; Mattiello A; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bueno-de-Mesquita HB; Monninkhof EM; Onland-Moret NC; Andresson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Merritt MA; Riboli E; Dossus L; Kaaks R
    Breast Cancer Res; 2015 Mar; 17(1):49. PubMed ID: 25887963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
    Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
    Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women.
    Trabert B; Bauer DC; Buist DSM; Cauley JA; Falk RT; Geczik AM; Gierach GL; Hada M; Hue TF; Lacey JV; LaCroix AZ; Tice JA; Xu X; Dallal CM; Brinton LA
    JAMA Netw Open; 2020 Apr; 3(4):e203645. PubMed ID: 32329771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.